Sign inGet started

venBio Global Strategic Fund IV, L.P.

Insider CIK 1862109 · ATTO 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ATTO Attovia Therapeutics, Inc. C Conversion deriv2026-08-062026-08-1021,477,273— $00SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion deriv2026-08-062026-08-107,636,362— $00SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion deriv2026-08-062026-08-106,179,219— $00SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion2026-08-062026-08-10665,147— $03,799,015SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion2026-08-062026-08-102,311,870— $02,311,870SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion2026-08-062026-08-10821,998— $03,133,868SEC↗
ATTO Attovia Therapeutics, Inc. P Buy2026-08-062026-08-10382,352$17.00 $6.50M4,181,367SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion deriv2026-08-062026-08-106,179,219— $00SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion deriv2026-08-062026-08-107,636,362— $00SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion deriv2026-08-062026-08-1021,477,273— $00SEC↗
ATTO Attovia Therapeutics, Inc. P Buy2026-08-062026-08-10382,352$17.00 $6.50M4,181,367SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion2026-08-062026-08-10665,147— —3,799,015SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion2026-08-062026-08-10821,998— —3,133,868SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion2026-08-062026-08-102,311,870— —2,311,870SEC↗